Clinical Trial Update: Psilocybin rTMS for Treatment Resistant Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at the University of Texas at Austin is testing psilocybin-assisted rTMS for treatment-resistant depression and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Texas at Austin | Conditions: Treatment Resistant Depression, MDD | Phase 2 | Status: RECRUITING